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OBJECTIVES: The aim of this study was to evaluate whether clinical test values from different laboratories in 
the Korean Genome and Epidemiology Study (KoGES) can be integrated through a statistical adjustment al-
gorithm with appropriate intra- and inter-laboratory reliability.
METHODS: External quality control data were obtained from the Korean Society for Laboratory Medicine 
and quadruplicated standardized serological samples (N=3,200) were manufactured in order to check the in-
tra- and inter-laboratory reliability for aspartic acid transaminase (AST), alanine transaminase (ALT), gamma-
glutamyl transpeptidase (γ-GTP), blood urea nitrogen (BUN), creatinine, uric acid (UA), fasting blood sugar 
(FBS), cholesterol, and triglyceride (TG). As an index of inter- and intra-rater reliability, Pearson’s correlation 
coefficient, intraclass correlation coefficients and kappa statistics were estimated. In addition, to detect the po-
tential for data integration, we constructed statistical compensation models using linear regression analysis with 
residual analysis, and presented the R-square values. 
RESULTS: All correlation coefficient values indicated good intra- and inter-laboratory reliability, which ranged 
from 0.842 to 1.000. Kappa coefficients were greater than 0.75 (0.75-1.00). All of the regression models based 
on the trial results had strong R-square values and zero sums of residuals. These results were consistent in the 
regression models using external quality control data.
CONCLUSION: The two laboratories in the KoGES have good intra- and inter-laboratory reliability for ten 
chemical test values, and data can be integrated through algorithmic statistical adjustment using regression equa-
tions.
KEY WORDS: Reliability, Statistical compensation model, Serological marker, The KoGES
INTRODUCTION The Korean Genome and Epidemiology Study (KoGES), a 
large population-based genomic cohort study supported by the 
Korea Centers for Disease Control and Prevention (KCDC), in-
vestigates risk factors for major diseases among Koreans, in 
particular focusing on gene-environment and gene-gene inter-
actions [1,2]. According to the standardized KoGES protocol 
12 biochemical analyses (fasting blood sugar [FBS]; gamma-
glutamyl transpeptidase [γ-GTP]; aspartic acid transaminase 
[AST]; alanine transaminase [ALT]; total cholesterol; triglycer-
ide [TG]; high density lipoprotein [HDL]-cholesterol; low den-
sity lipoprotein [LDL]-cholesterol; albumin; blood urea nitro-
gen [BUN]; uric acid [UA]; and creatinine), complete blood cell 
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counts including eight hematologic indices (white blood cells 
[WBC]; red blood cells [RBC]; hemoglobin [Hb]; hematocit 
[HCT]; mean corpuscular volume [MCV]; mean corpuscular 
hemoglobin [MCH]; mean corpuscular hemoglobin concentra-
tion [MCHC]; and platelets), and analysis of high sensitivity c-
reactive protein (HS-CRP) was conducted at two clinical labo-
ratories, and authenticated via external quality assessment 
(QA) by the Clinical and Laboratory Standards Institute (CLSI) 
and the Korean Society for Laboratory Medicine (KSLM). 
Clinical results from multiple laboratories may differ system-
atically [3-5]. Despite standardization of the blood test in the 
KoGES, potential discrepancies that may lead to significantly 
biased results in the pooled analyses remain. Moreover, the fun-
damental differences between the laboratories involving instru-
ments (Hitachi Co., Tokyo, Japan vs. Bayer HealthCare Ltd., 
Tarrytown, NY, USA), methods (enzymatic vs. colorimetry for 
γ-GTP) and reference values (adapted to each instrument) may 
result in heterogeneity. 
To minimize the potential analytic drift, appropriate standard-
ization such as calibration or statistical adjustment is warranted 
[6]. Thus, we investigated whether 1) the KoGES laboratories 
measure consistent test values regardless of time and environ-
mental conditions, 2) the laboratories are able to produce the 
same test values for future data pooling, and 3) future pooled 
analysis for serological parameters is possible using a statistical 
compensation model even though absolute test values differ 
between laboratories. In the present study, the intra- and inter-
laboratory reliability of the two clinical laboratories were as-
sessed using quadruplicated standardized serological samples 
and external quality control (QC) data, and the possibility that 
serological parameters produced by different laboratories can 
be integrated through statistical compensation models was eval-
uated. 
METHODS
To check the overall reliability of each laboratory, three years 
of QC data (2005, 2006, and 2007) for ten blood chemical tests 
(albumin, ALT, AST, γ-GTP, BUN, creatinine, UA, FBS, choles-
terol, and TG) were obtained from the KSLM. To evaluate intra- 
and inter-laboratory reliability, quadruplicated standardized se-
rological samples were prepared according to the Clinical and 
Laboratory Standards Institute (CLSI) guidelines [7]. Basic prin-
ciples including ‘at least 40 patient samples’, ‘at least 5 operat-
ing days’, and ‘analysis of each sample in duplicate within the 
same run’ were adopted. The principle of ‘at least 50% of sam-
ples outside the reference range’ was revised based on the true 
range of each test result in the KoGES and the general distribu-
tion in the Korean population. Finally, 40 samples were divided 
into five groups with two outlier groups A and E (Table 1).
The standardized serological samples were manufactured at 
the Department of Laboratory Medicine at the Seoul National 
University College of Medicine. Eight anonymous patient sam-
ples were prepared for five consecutive operating days. During 
the repeated trial, a total of 3,200 test serological samples were 
manufactured (eight patients×five operating days×duplication 
×repeated trial×ten test items×two laboratories). In detail, 
sample preparation was carried out as follows: 1) a nurse at the 
Department of Laboratory Medicine selected all serum samples 
with a volume of more than 3 mL before the day of the test, 2) 
a well-trained clinical pathologist selected eight serum samples 
Table 1. Total number of standardized serological samples (N=40) prepared according to the test value range
1
Group A Group B Group C Group D Group E
Range of  
test value
 Samples
(%) 
Range of  
test value
Samples
(%)
Range of  
test value
Samples
(%)
Range of  
test value
Samples
(%)
Range of  
test value
Samples
(%)
Albumin
3 <3   4 (10) 3-4 16 (40) 4-5 16 (40) >5 4 (10) -  -
ALT   <20   8 (20) 20-40   8 (20) 20-40 16 (40) 80-160 4 (10) 161-SL
2 4 (10)
AST   <20   8 (20) 20-40 12 (30) 20-40 12 (30) 80-160 4 (10) 161-SL
2 4 (10)
γ-GTP
3 0-30 16 (40) 31-60 16 (40) 120-240    4 (10) 241-SL
2 4 (10) -  -
BUN   <15   4 (10) 15-25 16 (40) 26-50   8 (20) 51-100 8 (20) 100-SL
2 4 (10)
Creatinine 0-1.0   8 (20) 1.1-2.5 12 (30) 2.5-5.0   8 (20) 5-10 8 (20) 11-SL
2 4 (10)
Uric acid    <3.0   8 (20) 3-5   8 (20) 5-8   8 (20) 8-10 8 (20) 11-SL
2 4 (10)
FBS   <50   4 (10) 51-110 16 (40) 111-150 12 (30) 151-250 4 (10) 251-SL
2 4 (10)
Cholesterol
3 120-180   8 (20) 181-220 12 (30) 221-260 12 (30) 261-400 8 (20) -  -
TG   <75   4 (10) 75-125 12 (30) 125-200 12 (30) 200-300 8 (20) 301-SL
2 4 (10)
ALT, alanine transaminase; AST, aspartic acid transaminase; γ-GTP, gamma-glutamyl transpeptidase; BUN, blood urea nitrogen; creatinine; UA, uric acid; FBS, 
fasting blood sugar; TG, triglyceride.
1Using 40 serum samples, the standardized serological samples were prepared from the number of specimens predetermined according to the range of test 
values. We prepared each sample twice, and thus 80 serum samples were acquired in this study; 
2The maximum value that could be detected by each in-
strument; 
3Albumin, γ-GTP, and cholesterol were divided into four categories based on both the KoGES data and normal ranges for the general Korean pop-
ulation.3
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on the morning of the test, 3) four 250 μL aliquots of each se-
rum (quadruplicated samples) were divided into plain tubes, 
and 4) a set of duplicated samples was delivered to each center. 
To minimize other sources of variation, sample delivery, storage 
conditions, and test time were consistent with a standardized 
protocol. On the day of the test, prepared samples were deliv-
ered to each laboratory between noon and 1 pm, and tests were 
conducted simultaneously at 3 pm. Serum selection and tests 
were not conducted on a Saturday, Sunday, or Monday. The first 
trial was conducted on November 29-30 and December 4-7, 
2007. On the 6th day of the first trial, additional tests for FBS, 
BUN, UA, and albumin with unacceptable values outside the 
reference range (from Groups A or E) were conducted. The sec-
ond trial was conducted over five days on December 11, 12, 
13, 14, and 20, 2007. 
The mean of the difference and the coefficient of variation 
(CV) between the duplicated test results at each laboratory were 
calculated to determine intra-rater reliability. Pearson’s correla-
tion coefficients and intra-class correlation (ICC) coefficients 
were estimated as indices of intra-rater reliability. To determine 
the inter-laboratory reliability, we estimated the mean and CV 
of the differences between the mean of 40 duplicated test val-
ues at Centers X and Y. The level of agreement between the two 
laboratories was assessed using Pearson’s correlation coeffi-
cients, ICC coefficients and the Bland-Altman Plot [8]. Kappa 
statistics were used to measure the agreement in diagnosis (nor-
mal vs. abnormal). Coefficient values of 0.81-1.00 and >0.75 
indicated ‘almost perfect’ and ‘substantial and excellent’, re-
spectively [9,10]. 
Statistical compensation models were constructed using lin-
ear regression analysis to determine the potential for data inte-
gration. The regression equation was as follows: (Test values at 
Center Y)=α (intercept)+β (slope)×(Test values at Center X). 
The model fitting was checked by both regression residual anal-
ysis and R-square values. All statistical analyses were performed 
using SAS version 9.2 (SAS Inc., Cary, NC, USA) and MedCalc 
version 11.5 (MedCalc Software, Inc, Mariakerke, Bel  gium).
The present study was approved by the Institutional Review 
Boards of Seoul National University Hospital and the National 
Cancer Center of Korea (C-0707-072-214).
RESULTS 
For intra-rater reliability at Center X, the mean differences 
ranged from 0.027 to 7.387. With the exception of AST (0.842), 
all correlation coefficients were greater than 0.997 (p<0.001). 
The ICC coefficients indicated excellent reliability that was grea-
ter than 0.836. Similarly, the mean differences at Center Y rang-
ed from 0.018 to 3.125, all Pearson’s correlation coefficients 
ranged from 0.989 to 0.999, and ICC coefficients ranged from 
0.990 to 1.000, indicating almost perfect intra-rater reliability. 
Inter-laboratory reliability between Center X and Y was highly 
comparable. The means of the absolute values of the differences 
between the mean of the 40 duplicated test values at Centers X 
and Y ranged from 0.095 to 9.737. All correlation coefficients 
were reliable. Though AST showed the lowest Pearson’s correla-
tion coefficient and an ICC coefficient equal to the intra-rater 
Table 2. Intra-rater reliability at each center and inter-laboratory reliability between the two test values at Centers X and Y
Intra-rater reliability Inter-laboratory reliability
Absolute value of mean (CV) of  
difference in two duplicated test  
values
1 at Center X
Absolute value of mean (CV) of  
difference in two duplicated test  
values
1 at Center Y
Absolute value of mean (CV) of difference   
between the two test values of Center X and Y
2
Mean (CV) 
of differ-
ence
Correla-
tion co-
efficient 
ICC coefficient  
(95% CI)
Mean (CV)  
of difference
Correla-
tion co-
efficient 
ICC coefficient  
(95% CI)
Mean (CV) 
of difference
Correla-
tion co-
efficient
ICC coefficient  
(95% CI)
Kappa coefficient  
(95% CI)
Albumin 0.027 (1.85) 0.997 0.997 (0.996-0.998) 0.018 (2.22) 0.998 0.998 (0.997-0.999) 0.095 (0.84) 0.986 0.984 (0.975-0.990) 0.962 (0.888-1.000)
ALT 0.437 (1.30) 0.999 1.000 (1.000-1.000) 2.173 (1.55) 0.996 0.997 (0.995-0.998) 2.693 (1.06) 0.997 0.997 (0.995-0.998) 1.000 (1.000-1.000)
AST 7.387 (4.12) 0.842 0.836 (0.755-0.891) 3.125 (2.34) 0.989 0.990 (0.984-0.993) 9.168 (2.80) 0.872 0.871 (0.807-0.915) 0.754 (0.567-0.941)
γ-GTP 0.325 (1.75) 0.999 1.000 (1.000-1.000) 1.050 (1.09) 0.999 1.000 (0.999-1.000) 4.700 (0.62) 0.999 0.994 (0.796-0.999) 0.786 (0.637-0.934)
BUN 0.175 (2.34) 0.999 1.000 (1.000-1.000) 0.700 (1.17) 0.999 0.999 (0.999-1.000) 3.532 (1.02) 0.999 0.987 (0.901-0.996) 0.975 (0.925-1.000)
Creatinine  0.028 (1.79) 0.999 1.000 (1.000-1.000) 0.031 (1.61) 0.999 1.000 (1.000-1.000) 0.138 (0.87) 0.999 0.999 (0.995-1.000) 0.873 (0.765-0.981)
Uric acid 0.085 (2.59) 0.997 0.997 (0.996-0.998) 0.038 (1.84) 0.999 1.000 (1.000-1.000) 0.562 (1.03) 0.984 0.970 (0.893-0.987) 0.925 (0.842-1.000)
FBS 1.262 (1.42) 0.999 1.000 (1.000-1.000) 0.725 (1.53) 0.999 1.000 (1.000-1.000) 6.968 (0.87) 0.999 0.995 (0.952-0.998) 0.871 (0.761-0.981)
Cholesterol  2.162 (0.86) 0.998 0.998 (0.997-0.999) 2.587 (2.04) 0.992 0.992 (0.988-0.995) 5.850 (0.75) 0.992 0.988 (0.946-0.995) 0.876 (0.771-0.980)
TG 1.000 (1.03) 0.999 1.000 (1.000-1.000) 1.500 (2.43) 0.999 0.999 (0.998-0.999) 9.737 (0.65) 0.995 0.991 (0.914-0.997) 0.974 (0.922-1.000)
ALT, alanine transaminase; AST, aspartic acid transaminase; γ-GTP, gamma-glutamyl transpeptidase; BUN, blood urea nitrogen; UA, uric acid; FBS, fasting 
blood sugar; TG, triglyceride; CV, coefficient of variation; ICC, intra-class correlation.
1Calculated as the absolute value of the difference in the mean of two duplicated test values at each center (n=80); 
2Calculated as the absolute value of the 
difference in the mean of two duplicated test values at Center X (n=80) and the mean of two duplicated test values at Center Y (n=80).4
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Figure 1. Scatter plots and Bland-Altman plots for each blood test item (Continued to the next page).
SD, standard deviation. 5
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Figure 1. (Continued from the previous page) Scatter plots and Bland-Altman plots for each blood test item.
SD, standard deviation. 6
Epidemiology and Health  2011;33:e2011004
Table 3. R-square values (sum of residuals)
1 on the fitting of linear 
regression models
2 using internal and external quality control data
KoGES 
trial
3
External QC data by KSLM
4 Range of 
slope 
difference Year 2007 Year 2006 Year 2005
Albumin 0.97  0.95  0.97  0.95  0.050-0.133
ALT 0.99  0.99  0.98  0.99  0.001-0.043
AST 0.70  0.99  1.00  1.00  0.011-0.206
γ-GTP 1.00  1.00  1.00  0.99  0.022-0.083
BUN 1.00  1.00  1.00  0.99  0.077-0.158
Creatinine  1.00  1.00  1.00  0.99  0.081-0.125
Uric acid 0.97  0.99  1.00  0.97  0.009-0.115
FBS 1.00  1.00  1.00  0.98  0.009-0.078
Cholesterol 0.98  0.99  1.00  0.96  0.007-0.030
TG 0.99  0.99  Not fitted
5  Not fitted
5 NA
ALT, alanine transaminase; AST, aspartic acid transaminase; γ-GTP, gamma-
glutamyl transpeptidase; BUN, blood urea nitrogen; UA, uric acid; FBS, fast-
ing blood sugar; TG, triglyceride; KoGES, Korean Genome and Epidemiol-
ogy Study; KSLM, Korean Society for Laboratory Medicine; QC, qua  lity con-
trol; NA, not applicable.
1Sums of residuals were all zero; 
2Equation forms are represented by (value 
of Center Y)=α (intercept)+β (slope)×(value of Center X).
3The quadruplicated standardized samples from 40 samples; 
4Three stan-
dardized samples were tested for external QC four times a year by the KS-
LM; 
5Different QC methods applied in the two laboratories in 2005 and 2006.
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Figure 1. (Continued from the previous page) Scatter plots and Bland-Altman plots for each blood test item.
SD, standard deviation. 
reliability, the values remained good at 0.872 and 0.871, re-
spectively. The kappa statistics showed attenuated reliability but 
all values were over 0.75 with substantial reliability (Table 2). 
Bland-Altman plots showed that most absolute differences be-
tween Center X and Y were within the 95% limit of agreement 
(Figure 1). 
Using the standardized serological samples, statistical com-
pensation models using linear regression analysis were construct-
ed to yield a mathematical relationship between the results of 
the two laboratories. With the exception of AST (R
2=0.70), all 
regression equations presented strong correlation coefficients 
(R
2>0.97). The regression equations for the three years, 2005, 
2006, and 2007, were estimated using external QC data ac-
quired from the KSLM. All correlation coefficient values were 
greater than 0.95 with the exception of TG, which used a differ-
ent QC method in the two laboratories in 2005 and 2006. All 
the results of the standardized serological samples and external 
QC data were consistent in the regression models (Table 3). 
In the residual analysis, the sums of residuals were all zero 
and for those residual plots that presented residuals between 
the actual y-values and the predicted values all residuals were 
randomly distributed around zero (data not shown).7
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DISCUSSION 
This study evaluated the possibility of integrating serological 
parameters from different laboratories participating in the Ko-
GES via a statistical adjustment algorithm with good intra- and 
inter-laboratory reliability. Our results indicated that the two 
laboratories had excellent intra- (correlation coefficient>0.84, 
ICC>0.83) and inter-laboratory reliability (correlation coeffi-
cient>0.87, ICC>0.87, and kappa>0.75) for ten chemical test 
values. Moreover, linear regression analysis to compensate for 
the discrepancy in test values between the two centers gave ex-
cellent R-square values and zero sums of residuals.
Poorly controlled data can lead to significantly biased results 
[11]. Given the participation of two laboratories in the KoGES, 
the issue of quality control should be carefully addressed. Like-
wise, a strategy for data integration should be established based 
on the reliability within and between the laboratories. The pres-
ent study indicated that regression equations with higher R-squ-
are values can compensate for the potential discrepancies cau-
sed by the use of different laboratories. Although the absolute 
values differed slightly, if intra- and inter-laboratory reliability 
can be assured, data integration may be successfully conducted 
using statistical compensation models. In terms of AST, γ-GTP 
and TG with relatively unstable results or insufficient external 
QC data, further replication studies focused on clinical features 
and test methodology are required. 
The issue of multiple laboratories is relevant not only for the 
KoGES but also for other large cohorts. Ideally, a single labora-
tory that passes a strict QC system should conduct all clinical 
tests according to accurate and standardized methods. Howev-
er, this is logistically difficult in reality. The most reasonable al-
ternatives are 1) choosing reliable laboratories, 2) developing a 
standardized protocol for clinical tests, 3) conducting and moni-
toring regular QC, and 4) integrating the KoGES database after 
statistical adjustment. For statistical adjustment, the regression 
analysis method can be used to check intra- and inter- rater re-
liability. 
Using the KoGES data, this study aimed to determine the 
possibility of integrating serological parameters produced from 
different laboratories via statistical compensation models. Our 
results indicate that the ten blood chemical tests analyzed at 
the two laboratories can be integrated through statistical adjust-
ments using regression equations. The existing external QC data 
should be used to correct the discrepancies in the other bio-
chemical tests and complete blood cell counts, or additional tri-
als with the standardized serological samples should be con-
ducted before data integration into the KoGES database.
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